Background: Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia. DM-related dyslipidemia are associated with complications resulting from progressive damage of various organs. CD36 is 88-kD, class B scavenger receptor, expressed on different types of cells. In diabetic patients, LDL particles are glycated with strong level; this increases CD36 expression, initiates foam cell formation and accelerates atherosclerosis. Objective: This study aimed to determine the correlation between serum CD36 level and lipid profile among patients with type 2 diabetes mellitus in Zeenam Specialized center, Khartoum State, Sudan, in a period between 2019 and 2022. Methodology: Hundred participants at different ages were included in this study; 70 were type 2 diabetic patients (cases) and 30 apparently healthy individual (control). 3 ml of venous blood were collected from the participants by using a sterile needle and syringe into a labeled plain container. Each sample was stood until complete clot occurs. Clotted blood sample was then centrifuged to obtain the serum. Then they were used for measurement of total cholesterol, LDL cholesterol, HDL cholesterol, triglyceride and soluble CD36 levels. Total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides were measured using Biosystem chemistry analyzer BTS-302. Serum CD36 was measured using Microplate Reader (URIT-660). Results: The results revealed that serum total cholesterol, LDL cholesterol, HDL cholesterol, and triglyceride levels were significantly higher in patients with type 2 diabetes mellitus compared with control (P = 0.03, P = 0.031, P = 0.000, P = 0.000) respectively, while there is no statistically significant differences in serum CD36 level between cases and control (P = 0.129). Also this study showed that there is no statistically significant correlation between serum CD36 level and total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, age and body mass index. Conclusion: This study concluded that there is no statistically significant difference in serum CD36 level between cases and control. And sCD36 level was not correlated with total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, body mass index, and age.
References
[1]
Sheleme, T., Mamo, G., Melaku, T. and Sahilu, T. (2020) Prevalence, Patterns and Predictors of Chronic Complications of Diabetes Mellitus at a Large Referral Hospital in Ethiopia: A Prospective Observational Study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 4909-4918. https://doi.org/10.2147/DMSO.S281992
[2]
Ma, Y., Xiong, J., Zhang, X., Qiu, T., Pang, H., Li, X. and Zhang, J. (2021) Potential Biomarker in Serum for Predicting Susceptibility to Type 2 Diabetes Mellitus: Free Fatty Acid 22:6. Journal of Diabetes Investigation, 12, 950-962. https://doi.org/10.1111/jdi.13443
[3]
Oraii, A., Shafiee, A., Jalali, A., Alaeddini, F., Saadat, S., Masoudkabir, F. and Franco, O.H. (2022) Prevalence, Awareness, Treatment, and Control of Type 2 Diabetes Mellitus among the Adult Residents of Tehran: Tehran Cohort Study. BMC Endocrine Disorders, 22, Article No. 248. https://doi.org/10.1186/s12902-022-01161-w
[4]
Puchałowicz, K. and Rać, M.E. (2020) The Multifunctionality of CD36 in Diabetes Mellitus and Its Complications—Update in Pathogenesis, Treatment and Monitoring. Cells, 9, 1877. https://doi.org/10.3390/cells9081877
[5]
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N. and Wang, D.W. (2022) The Role of CD36 in Cardiovascular Disease. Cardiovascular Research, 118, 115-129. https://doi.org/10.1093/cvr/cvaa319
[6]
Glatz, J. C. and Luiken, J. F. (2018) Dynamic Role of the Transmembrane Glycoprotein CD36 (SR-B2) in Cellular Fatty Acid Uptake and Utilization. Journal of Lipid Research, 59, 1084-1093. https://doi.org/10.1194/jlr.R082933
[7]
Jay, A.G., Chen, A.N., Paz, M.A., Hung, J.P. and Hamilton, J.A. (2015) CD36 Binds Oxidized Low Density Lipoprotein (LDL) in a Mechanism Dependent upon Fatty Acid Binding. Journal of Biological Chemistry, 290, 4590-4603. https://doi.org/10.1074/jbc.M114.627026
[8]
Park, Y. (2014) CD36, a Scavenger Receptor Implicated in Atherosclerosis. Experimental & Molecular Medicine, 46, e99. https://doi.org/10.1038/emm.2014.38
[9]
Rać, M.E., Krupa, B., Garanty-Bogacka, B., et al. (2012) Polymorphism of CD36 Gene, Carbohydrate Metabolism and Plasma CD36 Concentration in Obese Children. A Preliminary Study. Postępy Higieny i Medycyny Doświadczalnej (Online), 66, 954-958. https://doi.org/10.5604/17322693.1021112
[10]
Alkhatatbeh, M.J., Ayoub, N.M., Mhaidat, N.M., Saadeh, N.A. and Lincz, L.F. (2016) Soluble Cluster of Differentiation 36 Concentrations Are Not Associated with Cardiovascular Risk Factors in Middle-Aged Subjects. Biomedical Reports, 4, 642-648. https://doi.org/10.3892/br.2016.622
[11]
Kulkarni, N.B., Ganu, M.U., Godbole, S.G. and Deo, S.S. (2018) Assessment of Potential Biomarkers of Atherosclerosis in Indian Patients with Type 2 Diabetes Mellitus. The Indian Journal of Medical Research, 147, 169-176. https://doi.org/10.4103/ijmr.IJMR_852_16
[12]
Alkhatatbeh, M.J., Enjeti, A.K., Acharya, S., Thorne, R.F. and Lincz, L.F. (2013) The Origin of Circulating CD36 in Type 2 Diabetes. Nutrition & Diabetes, 3, e59. https://doi.org/10.1038/nutd.2013.1
[13]
Touré, M., Samb, A., Sène, M., Thiam, S., Mané, C.A.B., Sow, A.K., Ba-Diop, A., Kane, M.O., Sarr, M., Ba, A. and Gueye, L. (2022) Impact of the Interaction between the Polymorphisms and Hypermethylation of the CD36 Gene on a New Biomarker of Type 2 Diabetes Mellitus: Circulating Soluble CD36 (sCD36) in Senegalese Females. BMC Medical Genomics, 15, Article No. 186. https://doi.org/10.1186/s12920-022-01337-2
[14]
Kim, H.J., Moon, J.S., Park, I.R., Kim, J.H., Yoon, J.S., Won, K.C. and Lee, H.W. (2017) A Novel Index Using Soluble CD36 Is Associated with the Prevalence of Type 2 Diabetes Mellitus: Comparison Study with Triglyceride-Glucose Index. Endocrinology and Metabolism (Seoul, Korea), 32, 375-382. https://doi.org/10.3803/EnM.2017.32.3.375
[15]
Castelblanco, E., Sanjurjo, L., Falguera, M., Hernández, M., Fernandez-Real, J.M., Sarrias, M.R. and Mauricio, D. (2019) Circulating Soluble CD36 Is Similar in Type 1 and Type 2 Diabetes Mellitus versus Non-Diabetic Subjects. Journal of Clinical Medicine, 8, 710. https://doi.org/10.3390/jcm8050710